Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-17 5:25 pm Sale |
2022-01-12 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 3,225,700 7.100% |
-614,969 (-16.01%) |
Filing History |
| 2023-01-03 6:56 pm Sale |
2022-12-29 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 3,840,669 8.480% |
-516,223 (-11.85%) |
Filing History |
| 2022-12-20 5:13 pm Sale |
2022-12-16 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 4,356,892 9.620% |
-965,683 (-18.14%) |
Filing History |
| 2022-09-07 11:37 am Sale |
2022-08-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,109,425 4.560% |
-280,554 (-11.74%) |
Filing History |
| 2022-07-21 5:13 pm Purchase |
2022-07-20 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 5,322,575 11.500% |
5,322,575 (New Position) |
Filing History |
| 2022-07-20 5:12 pm Purchase |
2022-07-15 | 13D | Immunocore Holdings plc IMCR |
Baker Bros. Advisors LP | 4,685,690 9.930% |
1,333,333 (+39.77%) |
Filing History |
| 2022-03-17 08:19 am Purchase |
2022-03-01 | 13G | Immunocore Holdings plc IMCR |
Cross Nicholas John | 2,369,610 5.400% |
2,369,610 (New Position) |
Filing History |
| 2022-02-18 3:35 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Laing Ian Michael | 2,358,650 5.400% |
2,358,650 (New Position) |
Filing History |
| 2022-02-14 6:23 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 2,471,555 5.640% |
141,770 (+6.09%) |
Filing History |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,389,979 5.450% |
30,554 (+1.29%) |
Filing History |
| 2022-02-10 4:05 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
LILLY ELI & CO LLY |
2,548,145 5.800% |
2,548,145 (New Position) |
Filing History |
| 2021-10-15 1:17 pm Purchase |
2021-10-15 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,359,425 5.390% |
2,359,425 (New Position) |
Filing History |
| 2021-05-20 5:25 pm Unchanged |
2021-05-10 | 13D | Immunocore Holdings plc IMCR |
Baker Bros. Advisors LP | 3,352,357 7.700% |
0 (Unchanged) |
Filing History |
| 2021-04-19 4:25 pm Purchase |
2021-04-09 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 2,329,785 5.320% |
2,329,785 (New Position) |
Filing History |
| 2021-02-16 4:58 pm Purchase |
2021-02-16 | 13G | Immunocore Holdings plc IMCR |
Baker Bros. Advisors LP | 3,352,357 7.500% |
3,352,357 (New Position) |
Filing History |